A bone cancer known as osteosarcoma is genetically similar in dogs and human children, according to the results of a study published today by Tufts University and the Translational Genomics Research Institute (TGen), an affiliate ...
Jul 19, 2019
0
4
A research team led by scientists from the Broad Institute has uncovered a novel group of chemical inhibitors that can kill the bacteria that causes tuberculosis (TB). Importantly, these chemical compounds take aim at a previously ...
Jun 20, 2019
0
0
University of California, Davis professor Bruce Hammock has spent a 50-year career studying insects. He probably wouldn't be the Ph.D. considered most likely to shake up the multibillion-dollar prescription painkiller market.
May 1, 2019
1
29
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine's safety and tolerability as well as its ability to induce an immune response in healthy volunteers. Scientists at the ...
Apr 3, 2019
0
1
Over the past quarter-century, researchers have published hundreds of studies suggesting a small set of particular genes or gene-variants plays a substantial role in boosting susceptibility to depression. Such papers fueled ...
Apr 3, 2019
0
142
A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus has been designed in an international research effort. RSV is second only to malaria as a cause of infant mortality worldwide. The new vaccine ...
Mar 7, 2019
0
80
Vaccines that induce protective T-cell responses could protect against members across the filovirus family, according to a study published February 28 in the open-access journal PLOS Pathogens by Tomáš Hanke of the University ...
Feb 28, 2019
0
0
There is more positive news to report about the Ebola subunit vaccine candidate developed by University of Hawaiʻi at Mānoa scientist Axel Lehrer. The potential vaccine remains viable in extreme heat conditions for several ...
Feb 25, 2019
0
2
Political action committees (PACs) affiliated with physician organizations contribute more money to political candidates who oppose evidence-based policies to reduce firearm-related injuries than to those who support such ...
Feb 22, 2019
7
44
Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren't as effective as they could be. Oncologists haven't had the right tools to predict drug interactions, other than in costly ...
Feb 21, 2019
0
25
